DOW vs REPL · P/E 74, rev $42.96B vs $825.7M cap
Dow Inc (DOW) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
REPL does not have a complete income-statement cache yet.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. REPL currently screens at market cap $825.7M.
Not investment advice. Open the DOW and REPL stock pages for the full models.
Not investment advice.